Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients

Experimental Dermatology

Volumn 15, Issue 12, 2006, Pages 958-965

  Lira, Macarena Gomez ^a   Provezza, Lisa ^a   Malerba, Giovanni ^a   Naldi, Luigi ^b   Remuzzi, Giuseppe ^c   Boschiero, Luigino ^a   Forni, Alberto ^a   Rugiu, Carlo ^a   Piaserico, Stefano ^d   Alaibac, Mauro ^d   Turco, Alberto ^a   Girolomoni, Giampiero ^a   Tessari, Gianpaolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Centro Studi Gruppo Italiano di Studi Epidemiologici in Dermatologia   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

CYP1A1; GlutathioneS transferase; Non melanomaskin cancer; Polymorphisms; Transplantrecipients

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRANSFERASE; TSUKUBAENOLIDE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGE; AGED; ALLELISM; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; ITALY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; SKIN CANCER;

ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SKIN NEOPLASMS; TRANSPLANTS;

EID: 33750633647     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00500.x     Document Type: Article

References (52)

1. Berg D, Otley C C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002: 47: 1-17.
2. Liddingston M, Richardson A J, Higgins R M et al. Skin cancer in renal transplant recipient. Br J Surg 1998: 76: 1002-1005.
3. Moloney F J, Comber H, O'Lorcain P, O'Kelly P, Conlon P J, Murphy G M. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006: 154: 498-504.
4. Martinez J C, Otley C C, Stasko T et al. Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: A multicenter collaborative study. Arch Dermatol 2003: 139: 301-306.
5. Kovach B T, Sams H H, Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant patients. Clin Transplant 2005: 19: 726-734.
6. Heagerty A, Smith A, English J et al. Susceptibility to multiple cutaneous basal cell carcinomas: Significant interaction between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer 1996: 73: 44-48.
7. Mouret S, Sauvaigo S, Peinnequin A, Favier A, Beani J C, Leccia M T. E6* oncoprotein expression of human papillomavirus type-16 determines different ultraviolet sensitivity related to glutathione and glutathione peroxidase antioxidant defence. Exp Dermatol 2005: 14: 401-410.
8. Larsson P, Andersson E, Johansson U, ̈llinger K, Rosdahl I. Ultraviolet A and B affect human melanocytes and keratinocytes differently. A study of oxidative alterations and apoptosis. Exp Dermatol 2005: 14: 117-123.
9. Karagas M R, Tosteson T D, Blum J et al. Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations. Am J Epidemiol 2000: 152: 84-90.
10. Yeh S, How S W, Lin C S. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 1968: 21: 312-339.
11. Suskind R R. Environment and the skin. Med Clin North Am 1990: 74: 307-324.
12. Gelardi A, Morini F, Dusatti F, Penco S, Ferro M. Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. Toxicol In Vitro 2001: 15: 701-711.
13. Afaq F, Mukhtar H. Effects of solar radiation on cutaneous detoxification pathways. J Photochem Photobiol B 2001: 63: 61-69.
14. Lear J T, Smith A G, Strange R C, Fryer A A. Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 2000: 142: 8-15.
15. Baron J. In situ sites for xenobiotic activation and detoxication: implications for the differential susceptibility of cells to the toxic actions of environmental chemicals. Prog Histochem Cytochem 1991: 23: 32-44.
16. Strange R C, Fryer A A. The glutathione S-transferases: Influence of polymorphism on susceptibility to non-familial cancer. In: Boffetta P, Caoraso N, Cuzick J, Lang M, Vineis P, eds. Metabolic Polymorphisms and Cancer. Lyon: IARC Scientific Publications, 1999: 303-322.
17. Hayes J D, Strange R C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000: 61: 154-166.
18. Zimniak P, Nanduri B, Pikula S et al. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucine and valine at position 104 differ in enzymatic properties. Eur J Biochem 1994: 224: 275-280.
19. Srivastava S K, Singhal S S, Hu X, Awasthi Y C, Zimniak P, Singh S V. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 1999: 366: 89-94.
20. Hu X, Xia H, Scrivastava SK et al. Activity of four allelic forms of glutathione S-transferase hGSTP1 -1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997: 238: 397-402.
21. Heagerty A H M, Fitzgerald D, Smith A et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous malignancy. Lancet 1994: 343: 266-268.
22. Watson M A, Stewart R K, Smith G B, Massey T E, Bell D A. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998: 19: 275-280.
23. Pemble S, Schroeder K R, Spencer S R et al. Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994: 300: 271-276.
24. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan S C, Ankathil R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 2005: 50: 618-627.
25. Landi S, Gemignami F, Moreno V et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 2005: 15: 535-546.
26. Egan K M, Cai Q, Shu X O, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: Results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2004: 13: 197-204.
27. Kote-Jarai Z, Easton D, Edwards S M, et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001: 11: 325-330.
28. Nakazato H, Suzuki K, Matsui H, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003: 23: 2897-2902.
29. Inskip A, Elexperu-Camiruaga J, Buxton N et al. Identification of polymorphisms at the glutathione-S-transferase GSTM3 locus: Evidence for linkage with GSTM1A. Biochem J 1995: 312: 713-737.
30. Ramsay H M, Harden P N, Reece S et al. Polymorphism in glutathione S-transferases are associated with altered risk of non-melanoma skin cancer in renal transplantation recipients: A preliminary analysis. J Invest Dermatol 2001: 117: 251-255.
31. Marshall S E, Bordea C, Haldar N A et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000: 58: 2186-2193.
32. Fryer A A, Ramsay H M, Lovatt T J et al. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 2005: 26: 185-191.
33. Raunio H, Pasanen M, Maenpaa J, Hakkola J, Pelkonen O. Expression of extrahepatic cytochrome P450 in humans. In: Pacific G M, Fracchia G N, eds. Advances in Drug Metabolism in Man. Brussels: Directorate-General Science, Research and Development, European Commission, 1995: 233-287.
34. Barouki R, Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: Mechanism and biological implications. Biochem Pharmacol 2001: 61: 511-516.
35. Taiola E, Ford J, Trachman J, Li Y, Demopoulos R, Garte S. Lung cancer risk and CYP1A1 genotype in African-Americans. Carcinogenesis 1998: 19: 813-817.
36. Raimondi S, Boffetta P, Anttila S et al. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res 2005: 592: 45-57.
37. Ng DP, Tan KW, Zhao B, Seow A. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: Influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation. Cancer Causes Control 2005: 16: 399-405.
38. Yang CX, Matsuo K, Wang ZM, Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: A meta-analysis of the literature. World J Gastroenterol 2005: 11: 2531-2538.
39. Yengi L, Inskip A, Gilford J et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996: 56: 1974-1977.
40. Lear J T, Smith A G, Bower B et al. Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes, and their interaction. J Invest Dermatol 1997: 108: 519-522.
41. Ramachandran S, Lear J T, Ramsay H et al. Presentation with multiple cutaneous basal cell carcinomas: Association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotypes. Cancer Epidemiol Biomarkers Prev 1999: 8: 61-67.
42. Vineis P, Veglia F, Anttila S et al. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: A pooled analysis of gene-gene interactions. Biomarkers 2004: 9: 298-305.
43. Hung R J, Boffetta P, Brockmoller J et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis 2003: 24: 875-882.
44. Belogubova E V, Ulibina Y M, Suvorova I K et al. Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects. J Cancer Res Clin Oncol 2006: 14: 1-5.
45. Murata M, Watanabe M, Yamanaka M et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001: 165: 171-177.
46. Acevedo C, Opazo J L, Huidobro C, Cabezas J, Iturrieta J, Quinomes Sepulveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 2003: 57: 111-117.
47. Li H, Chen X L, Li H Q. Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 2005: 11: 5757-5762.
48. Halloran P F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004: 351: 2715-2729.
49. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 1991: 110: 407-411.
50. Sugawara T, Nomura E, Sagawa T, Sakuragi N, Fujimoto S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer 2003: 13: 785-790.
51. Armitage P, Berry G. The planning of statistical investigations. In: Armitage P, Berry G, eds. Statistical Methods in Medical Research, 4th edn. Oxford: Blackwell Scientific Publications, 1994: 175-185.
52. Vaury C, LainèR, Nogulez P et al. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 1995: 55: 5520-5523.